Meta faces a significant legal challenge over its platforms' effects on young users as a major state-led lawsuit enters trial. The company argues that social media addiction is not a clinically recognized condition, positioning its defense around the absence of formal psychiatric diagnosis. Multiple US states brought the case alleging that Meta knowingly designed Facebook and Instagram to exploit children's psychological vulnerabilities and hook them into compulsive use.
The trial centers on internal Meta documents and communications that may reveal how the company approached youth engagement. Plaintiffs argue Meta prioritized growth metrics and user retention over child safety, employing algorithmic features specifically designed to maximize time spent on platform. The lawsuit challenges Meta's business model at its core, claiming the company understood the addictive potential of its products yet failed to implement adequate safeguards.
Meta's position that addiction lacks clinical validity represents a critical legal distinction. The company may argue its products function as designed without meeting psychological dependency thresholds recognized by medical authorities. However, mounting research from independent scientists and prior regulatory findings contradict this stance. Facebook and Instagram face documented risks including disrupted sleep, body image issues, and depression among teenage users.
This case reflects broader regulatory pressure Meta faces globally. The European Union, UK, and Australia have all scrutinized Meta's youth-targeting practices. A settlement with the FTC previously required Meta to address child safety on its platforms, though critics argue enforcement remained weak.
The trial's outcome could reshape how social media companies design products for minors. Victory for the states might trigger mandatory design changes, increased transparency requirements, or substantial financial penalties. Meta's advertising model depends on engagement metrics, making any restrictions on addictive design features potentially costly. The verdict will clarify whether regulatory systems can hold tech giants accountable for products engineered to maximize user dependency.